Prometheus Biosciences
RXDX
$199.92
Share price
0.00%
Change (1 day)
360.96%
Change (1 year)
Categories
Earnings for Prometheus Biosciences (RXDX)
Earnings in 2023 (TTM): -$0.17 B
According to Prometheus Biosciences's latest financial reports the company's current earnings (TTM) are -$0.17 B. In 2022 the company made an earning of -$0.15 B a decrease over its 2021 earnings that were of -$89.36 M.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Prometheus Biosciences from 2020 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
| 2023 (TTM) | -$0.17 B | 11.53% |
| 2022 | -$0.15 B | 61.5% |
| 2021 | -$89.36 M | 208.04% |
| 2020 | -$29.01 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Epizyme EPZM | -$0.19 B | 14.06% | 🇺🇸 USA |
 Akebia Therapeutics AKBA | -$96.81 M | -39.86% | 🇺🇸 USA |
 Agenus
AGEN | -$0.21 B | 27.97% | 🇺🇸 USA |